The 16 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 181.50, with a high estimate of 270.00 and a low estimate of 126.00. The median estimate represents a +42.15% increase from the last price of 127.68.
The current consensus among 17 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.06
Reporting Date Mar 02
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.